Brentuximab
Product Specifications
CAS Number
2088770-90-3
Target
ADC Antibody, TNF
Related Pathways
Antibody-drug Conjugate/ADC Related, Apoptosis
Purity
0.992
Bioactivity
Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkin's lymphoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
